JP2013515494A5 - - Google Patents

Download PDF

Info

Publication number
JP2013515494A5
JP2013515494A5 JP2012546416A JP2012546416A JP2013515494A5 JP 2013515494 A5 JP2013515494 A5 JP 2013515494A5 JP 2012546416 A JP2012546416 A JP 2012546416A JP 2012546416 A JP2012546416 A JP 2012546416A JP 2013515494 A5 JP2013515494 A5 JP 2013515494A5
Authority
JP
Japan
Prior art keywords
peg
matrix
combination
inulin
impregnated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012546416A
Other languages
English (en)
Japanese (ja)
Other versions
JP5899118B2 (ja
JP2013515494A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/070389 external-priority patent/WO2011080160A1/en
Publication of JP2013515494A publication Critical patent/JP2013515494A/ja
Publication of JP2013515494A5 publication Critical patent/JP2013515494A5/ja
Application granted granted Critical
Publication of JP5899118B2 publication Critical patent/JP5899118B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012546416A 2009-12-29 2010-12-21 核酸溶出の改良 Active JP5899118B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29065209P 2009-12-29 2009-12-29
US61/290,652 2009-12-29
PCT/EP2010/070389 WO2011080160A1 (en) 2009-12-29 2010-12-21 Improvements to nucleic acid elution

Publications (3)

Publication Number Publication Date
JP2013515494A JP2013515494A (ja) 2013-05-09
JP2013515494A5 true JP2013515494A5 (https=) 2015-06-18
JP5899118B2 JP5899118B2 (ja) 2016-04-06

Family

ID=43743431

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012546416A Active JP5899118B2 (ja) 2009-12-29 2010-12-21 核酸溶出の改良

Country Status (7)

Country Link
US (3) US20120289690A1 (https=)
EP (1) EP2519631B1 (https=)
JP (1) JP5899118B2 (https=)
CN (1) CN102725406B (https=)
AU (1) AU2010338349B2 (https=)
CA (1) CA2785913C (https=)
WO (1) WO2011080160A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2519631B1 (en) * 2009-12-29 2017-02-15 GE Healthcare Bio-Sciences Corp. Improvements to nucleic acid elution
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US9534214B2 (en) 2013-10-31 2017-01-03 General Electric Company Substrates and associated methods for elution of nucleic acids
US9719082B2 (en) 2013-10-31 2017-08-01 General Electric Company Substrates and associated methods for elution of nucleic acids
CN108473932B (zh) 2015-09-09 2022-07-15 集联健康有限公司 用于样品收集、稳定化和保存的系统、方法和装置
US10000742B2 (en) * 2015-11-19 2018-06-19 General Electric Company Device and method of collection for RNA viruses
CN105462961B (zh) * 2016-01-14 2019-04-19 苏州市公安局 一种提取核酸的方法及试剂盒
TWI882519B (zh) 2017-01-10 2025-05-01 美商集聯健康有限公司 用於收集和儲存來自受試者之血液的裝置
JP2021145642A (ja) 2020-03-23 2021-09-27 株式会社リコー 担体及び検査方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990003959A1 (en) 1988-10-05 1990-04-19 The Flinders University Of South Australia Solid medium and method for dna storage
US5496562A (en) * 1988-10-05 1996-03-05 Flinders Technologies Pty Ltd Solid medium and method for DNA storage
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
US5124444A (en) * 1989-07-24 1992-06-23 Microprobe Corporation Lactam-containing compositions and methods useful for the extraction of nucleic acids
US5939259A (en) 1997-04-09 1999-08-17 Schleicher & Schuell, Inc. Methods and devices for collecting and storing clinical samples for genetic analysis
AU4353500A (en) * 1999-04-30 2000-11-17 Whatman, Inc. Substrate including anionic detergent for purifying nucleic acid
SE9904475D0 (sv) * 1999-12-08 1999-12-08 Artursson Nucleic acid delivery system
JP3776334B2 (ja) * 2001-07-11 2006-05-17 株式会社富士薬品 イヌリン含有製剤
CA2484062A1 (en) * 2001-08-20 2003-02-27 James C. Davis Dna purification and recovery from high particulate and solids samples
CA2465961A1 (en) * 2001-11-06 2003-05-15 Cortex Biochem, Inc. Isolation and purification of nucleic acids
EP1451320B1 (en) * 2001-11-15 2008-01-09 Whatman Inc. Materials and methods for releasing genetic material
US20040033546A1 (en) * 2002-04-10 2004-02-19 The Trustees Of Columbia University In The City Of New York Novel microarrays and methods of use thereof
BRPI0415850A (pt) * 2003-10-23 2007-01-02 Alza Corp composição de dna estabilizado para o revestimento de micro projeções
US20060153920A1 (en) * 2004-09-24 2006-07-13 Ketan Amin Lyophilized pharmaceutical compositions
US7727718B2 (en) * 2005-01-04 2010-06-01 Molecular Research Center, Inc. Reagents for storage and preparation of samples for DNA analysis
EP2519631B1 (en) * 2009-12-29 2017-02-15 GE Healthcare Bio-Sciences Corp. Improvements to nucleic acid elution

Similar Documents

Publication Publication Date Title
JP2013515494A5 (https=)
JP2011517729A5 (https=)
JP2011506530A5 (https=)
MX2012013375A (es) Peptido c pegilado.
JP2016525888A5 (https=)
JP2017514877A5 (https=)
CL2015000532A1 (es) Molécula de enlace a interleuquina 18 (il-18); anticuerpo; polinucleótido que lo codifica; vector; célula huésped; composición farmacéutica; uso para tratar sarcoidosis y otras inmunodeficiencias; y kit de diagnóstico.
JP2015512729A5 (https=)
JP2012111758A5 (https=)
CL2015000420A1 (es) Anticuerpo de unión a gfr alfa 3 (gfra3); ácido nucleico que lo codifica; vector; método para producirlo; composición farmacéutica que lo comprende; y uso para tratar una afección o enfermedad relacionada con gfra3.
JP2014526140A5 (https=)
JP2012031285A5 (https=)
JP2012204203A5 (https=)
JP2013527039A5 (https=)
JP2010049241A5 (https=)
JP2008188757A5 (https=)
CL2014003167A1 (es) Molécula de unión que se une específicamente a inteleuquina 6 (il-6); composición farmacéutica que la comprende; ácido nucleico; vector; célula huésped; y uso para tratar enfermedad o trastorno asociado a il-6.
EP2794779A4 (en) SOLVENT COMPOSITIONS WITH 1-CHLORO-3,3,3-TRIFLUORPROPES AND USES THEREOF
EP2806731A4 (en) AGAINST DISEASE RESISTANT CITRUS COMPOSITIONS, ORGANISMS, SYSTEMS AND PROCEDURES
JP2011037885A5 (https=)
JP2009249685A5 (https=)
JP2011021155A5 (https=)
JP2012115928A5 (https=)
JP2011515327A5 (https=)
JP2011082627A5 (https=)